CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,183,480 | -2.3% | 136,230 | +20.8% | 0.00% | 0.0% |
| Q2 2023 | $6,329,617 | +53727.9% | 112,747 | -56.6% | 0.00% | -57.1% |
| Q1 2023 | $11,759 | +2280.4% | 259,977 | +2040.8% | 0.01% | – |
| Q4 2022 | $494 | -99.9% | 12,144 | +26.4% | 0.00% | – |
| Q3 2022 | $628,000 | -48.3% | 9,611 | -51.9% | 0.00% | -100.0% |
| Q2 2022 | $1,215,000 | -71.2% | 20,000 | -70.2% | 0.00% | -66.7% |
| Q1 2022 | $4,217,000 | -86.5% | 67,188 | -83.7% | 0.00% | -81.2% |
| Q4 2021 | $31,325,000 | +26.2% | 413,366 | +86.5% | 0.02% | +6.7% |
| Q3 2021 | $24,815,000 | +27.8% | 221,700 | +84.8% | 0.02% | +36.4% |
| Q2 2021 | $19,417,000 | +19.7% | 119,939 | -9.9% | 0.01% | -8.3% |
| Q1 2021 | $16,220,000 | +70.4% | 133,112 | +114.1% | 0.01% | +100.0% |
| Q4 2020 | $9,521,000 | +184.2% | 62,185 | +36.4% | 0.01% | +20.0% |
| Q2 2020 | $3,350,000 | -82.4% | 45,592 | -85.4% | 0.01% | -79.2% |
| Q4 2019 | $19,029,000 | +335.8% | 312,433 | +193.3% | 0.02% | +242.9% |
| Q3 2019 | $4,366,000 | +46.6% | 106,538 | +58.6% | 0.01% | +75.0% |
| Q3 2018 | $2,979,000 | +33.3% | 67,179 | -29.4% | 0.00% | +33.3% |
| Q4 2017 | $2,234,000 | +66.1% | 95,130 | +26.4% | 0.00% | +50.0% |
| Q3 2017 | $1,345,000 | +154.3% | 75,272 | +128.1% | 0.00% | +100.0% |
| Q2 2017 | $529,000 | +119.5% | 33,000 | +177.0% | 0.00% | 0.0% |
| Q4 2016 | $241,000 | – | 11,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |